Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial

2016233 citationsJournal Article

Authors

Reduced inequalities

Published in: The Lancet Oncology

Volume 18, Issue 2, pp. 241-250

Field-Weighted Citation Impact: 18.91